HSBC Holdings’s Realm Therapeutics plc American Depositary Shares RLM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-15,222
Closed -$43K 3209
2019
Q2
$43K Sell
15,222
-515,328
-97% -$1.7M ﹤0.01% 2661
2019
Q1
$2.04M Buy
+530,550
New +$1.49M ﹤0.01% 1508

HSBC Holdings's RLM Position: Q3 2019 in Review

HSBC Holdings sold out of Realm Therapeutics plc American Depositary Shares (RLM) in Q3 2019, closing a stake of 15,222 shares — an estimated $43K sold.

HSBC Holdings first reported a position in RLM in Q1 2019 and held it in 2 quarters. The position peaked at $2.04M in Q1 2019. 0 funds tracked by Wall St. Rank hold RLM as of Q3 2019.

  • HSBC Holdings reported no remaining Realm Therapeutics plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • HSBC Holdings sold 15,222 Realm Therapeutics plc American Depositary Shares shares in Q3 2019, an estimated $43K.
  • HSBC Holdings first reported a position in Realm Therapeutics plc American Depositary Shares in Q1 2019 and held it in 2 quarters.
  • HSBC Holdings's Realm Therapeutics plc American Depositary Shares position peaked at $2.04M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Realm Therapeutics plc American Depositary Shares as of Q3 2019.

Based on HSBC Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.